In late December, Circuit Court Judge Roger Couch finalized a $327 million verdict against pharmaceutical giant Johnson & Johnson for the way it marketed its antipsychotic drug, Risperdal.
On or about the same day, he also gave another drug maker, AstraZeneca Pharmaceutical, the green light to move forward with a challenge to South Carolina’s action against the company for the marketing of its own antipsychotic drug, Seroquel, on the grounds that the state attorney general’s office had compromised its independence in pursuing the case.
Tagged with: Pharmaceutical verdict
Read More »